Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial

Autor: Matilda Appelgren, Helena Sackey, Yvonne Wengström, Karin Johansson, Johan Ahlgren, Yvette Andersson, Leif Bergkvist, Jan Frisell, Dan Lundstedt, Lisa Rydén, Malin Sund, Sara Alkner, Birgitte Vrou Offersen, Tove Filtenborg Tvedskov, Peer Christiansen, Jana de Boniface

Publikováno v: Breast, Vol 63, Iss , Pp 16-23 (2022)

Introduction: This report evaluates whether health related quality of life (HRQoL) and patient-reported arm morbidity one year after axillary surgery are affected by the omission of axillary lymph node dissection (ALND). Methods: The ongoing internat

Externí odkaz: https://doaj.org/article/c3a67ab10222469f89769b45423a329c

Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy : Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study

Autor: Maggie, Banys-Paluchowski, Maria Luisa, Gasparri, Jana, de Boniface, Oreste, Gentilini, Elmar, Stickeler, Steffi, Hartmann, Marc, Thill, Isabel T, Rubio, Rosa, Di Micco, Eduard-Alexandru, Bonci, Laura, Niinikoski, Michalis, Kontos, Guldeniz, Karadeniz Cakmak, Michael, Hauptmann, Florentia, Peintinger, David, Pinto, Zoltan, Matrai, Dawid, Murawa, Geeta, Kadayaprath, Lukas, Dostalek, Helidon, Nina, Petr, Krivorotko, Jean-Marc, Classe, Ellen, Schlichting, Matilda, Appelgren, Peter, Paluchowski, Christine, Solbach, Jens-Uwe, Blohmer, Thorsten, Kühn, The Axsana Study Group

Publikováno v: Cancers 13(7), 1565 (2021). doi:10.3390/cancers13071565 special issue: "Special Issue "Clinical Trials in Breast Cancer" / Special Issue Editor: Prof. Dr. Gilles Freyer, Guest Editor"
Cancers
Cancers, Vol 13, Iss 1565, p 1565 (2021)

Cancers 13(7), 1565 (2021). doi:10.3390/cancers13071565 special issue: "Special Issue "Clinical Trials in Breast Cancer" / Special Issue Editor: Prof. Dr. Gilles Freyer, Guest Editor"
Published by MDPI, Basel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d149b4ced7c35cd3b51e99d1d01a56e1

Abstract OT-04-02: The AXSANA trial (AXillary Surgery After NeoAdjuvant treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)

Autor: Thorsten Kühn, Jana de Boniface, Steffi Hartmann, Hans-Christian Kolberg, Michael Untch, Matilda Appelgren, Christine Solbach, Elmar Stickeler, Oreste Gentilini, Maggie Banys-Paluchowski, Marina Mangold, Eubreast, Jens-Uwe Blohmer, Marc Thill

Publikováno v: Cancer Research. 81:OT-04

Background The optimal surgical staging of the axilla in patients who convert from a clinically positive (cN+) to a clinically negative node status (ycN0) through neoadjuvant chemotherapy is still unclear. Widely diverse techniques such as full Axill

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::83e9a6444b6447358d5eeb91322a8ce2
https://doi.org/10.1158/1538-7445.sabcs20-ot-04-02